KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Other Accumulated Expenses (2016 - 2021)

Resmed (RMD) has disclosed Other Accumulated Expenses for 12 consecutive years, with $12.3 million as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million, compared with a TTM value of $12.3 million through Jun 2021, down 1.77%, and an annual FY2021 reading of $12.3 million, down 1.77% over the prior year.
  • Other Accumulated Expenses was $12.3 million for Q2 2021 at Resmed, down from $12.5 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $41.2 million in Q2 2019 and bottomed at $10.9 million in Q2 2017.
  • Average Other Accumulated Expenses over 5 years is $17.6 million, with a median of $12.3 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses surged 274.91% in 2019, then plummeted 69.7% in 2020.
  • Year by year, Other Accumulated Expenses stood at $10.9 million in 2017, then increased by 0.93% to $11.0 million in 2018, then soared by 274.91% to $41.2 million in 2019, then tumbled by 69.7% to $12.5 million in 2020, then decreased by 1.77% to $12.3 million in 2021.
  • Business Quant data shows Other Accumulated Expenses for RMD at $12.3 million in Q2 2021, $12.5 million in Q2 2020, and $41.2 million in Q2 2019.